| |
| |
|
| Insider
Information: |
Woodhouse David J |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
35,129 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,565 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
35,129 |
|
|
| Total
Value |
$17,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ngm Biopharmaceuticals Inc |
NGM |
|
2024-04-05 |
0 |
2024-04-05 |
0 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Director |
2021-08-11 |
35,129 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NGM |
Ngm Biopharmaceuticals In... |
Chief Executive Officer |
• • – |
2024-04-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(23,993) |
0 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Executive Officer |
• • – |
2024-04-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(97,654) |
0 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-16 |
4 |
D |
$1.34 |
$17,463 |
D/D |
(13,032) |
131,822 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Executive Officer |
• • – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
127,200 |
144,854 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-12-29 |
4 |
OE |
$7.70 |
$137,989 |
D/D |
17,654 |
17,654 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-11-18 |
4 |
OE |
$7.54 |
$113,100 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-11-18 |
4 |
AS |
$20.02 |
$300,300 |
D/D |
(15,000) |
0 |
0 |
% |
|
| SRZN |
Surrozen Ord Shs |
Director |
– • – |
2021-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,129 |
|
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
CEO and acting CFOOfficer |
• • – |
2019-04-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
80,000 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
